[H. pylori eradication therapy compared with antisecretory non-eradication therapy for the prevention of recurrent bleeding stomach ulcer].
Dam
Annette
A
Medicinsk Gastroenterologisk Afdeling S. Odense Universitetshospital. annettedam@compaqnet.dk
Schaffalitzky de Muckadell
Ove B
OB
D000863:Antacids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D019317:Evidence-Based Medicine; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000382:microbiology; D016480:Helicobacter pylori / Q000187:drug effects*; D006801:Humans; D015201:Meta-Analysis as Topic; D010438:Peptic Ulcer Hemorrhage / Q000382:microbiology / Q000517:prevention & control*; D055502:Secondary Prevention; D013276:Stomach Ulcer / Q000188:drug therapy* / Q000382:microbiology
D000863:Antacids; D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents